Prostate cancer in African-American men and polymorphism in the calcium-sensing receptor

Cancer Biology and Therapy

Volumn 9, Issue 12, 2010, Pages 994-999

  Schwartz, Gary G ^a   John, Esther M ^b,c   Rowland, Glovioell ^d   Ingles, Sue A ^d  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^b NORTHERN CALIFORNIA CANCER CENTER   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

African Americans; Calcium sensing receptor; Genetics; Prostate cancer

Indexed keywords

CALCIUM; CALCIUM SENSING RECEPTOR; DNA;

ADULT; ADVANCED CANCER; AFRICAN AMERICAN; AGED; ARTICLE; CANCER RISK; CASR GENE; CONTROLLED STUDY; DISEASE SEVERITY; GENE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; GROUPS BY AGE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PROSTATE CANCER; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED STATES;

AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; ALLELES; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS; RECEPTORS, CALCIUM-SENSING; RISK FACTORS;

EID: 77954409303     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.9.12.11689     Document Type: Article

References (31)

1. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007; 18:581-92.
2. Maddams J, Brewster D, Gavin A, Steward J, Elliott J, Utley M, Moller H. Cancer prevalence in the United Kingdom: estimates for 2008. Br J Cancer 2009; 101:541-7.
3. John EM, Schwartz GG, Koo J, Van Den Berg D, Ingles SA. Sun exposure, vitamin D receptor gene polymorphisms, and risk of advanced prostate cancer. Cancer Res 2005; 659:5470-9.
4. Schwartz GG. Vitamin D and the epidemiology of prostate cancer. Semin Dial 2005; 18:276-89.
5. Rukin NJ, Luscombe C, Moon S, Bodiwala D, Liu S, Saxby MF, et al. Prostate cancer susceptibility is mediated by interactions between exposure to ultraviolet radiation and polymorphisms in the 5′ haplotype block of the vitamin D receptor gene. Cancer Lett 2007; 247:328-35.
6. Chen L, Davey Smith G, Evans DM, Cox A, Lawlor DA, Donovan J, et al. Genetic variants in the vitamin D receptor are associated with advanced prostate cancer at diagnosis: Findings from the prostate testing for cancer and treatment study and a systematic review. Cancer Epidemiol Biomarkers Prev 2009; 18:2874-81.
7. Skinner HG, Schwartz GG. Serum calcium and incident and fatal prostate cancer in the national health and nutrition examination survey. Cancer Epidemiol Biomarkers Prev 2008; 17:2302-5.
8. Skinner HG, Schwartz GG. A prospective study of total and ionized serum calcium and fatal prostate cancer. Cancer Epidemiol Biomarkers Prev 2009; 18:575-8.
9. Tfelt-Hansen J, Brown EM. The calcium-sensing receptor in normal physiology and pathophysiology: a review. Crit Rev Clin Lab Sci 2005; 42:35-70.
10. Lin KI, Chattopadhyay N, Bai M, Alvarez R, Dang CV, Baraban JM, et al. Elevated extracellular calcium can prevent apoptosis via the calcium-sensing receptor. Biochem Biophys Res Commun 1998; 239:325-31.
11. Dhanasekaran SM, Barrette TR, Ghosh D, Shah R, Varambally S, Kurachi K, et al. Delineation of prognostic biomarkers in prostate cancer. Nature 2001; 412:822-6.
12. Schwartz GG. Prostate cancer, serum parathyroid hormone, and the progression of skeletal metastases. Cancer Epidemiol Biomarkers Prev 2008; 17:478-83.
13. Gomes RR Jr, Buttke P, Paul EM, Sikes RA. Osteosclerotic prostate cancer metastasis to murine bone are enhanced with increased bone formation. Clin Exp Metastasis 2009; 26:641-51.
14. Dong LM, Ulrich CM, Hsu L, Duggan DJ, Benitez DS, White E, et al. Genetic variation in calcium-sensing receptor and risk for colon cancer. Cancer Epidemiol Biomarkers Prev 2008; 17:2755-65.
15. Pike MC, Peters RK, Cozen W, Probst-Hensch NM, Felix JC, Wan PC, Mack TM. Estrogen-progestin replacement therapy and endometrial cancer. J Natl Cancer Inst 1997; 89:1110-6. (Pubitemid 27337924)
16. Yost K, Perkins C, Cohen R, Morris C, Wright W. Socioeconomic status and breast cancer incidence in California for different race/ethnic groups. Cancer Causes Control 2001; 12:703-11.
17. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21:263-5.
18. Brown EM, Gamba G, Riccardi D, Lombardi M, Butters R, Kifor O, et al. Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid. Nature 1993; 366:575-80.
19. Brown EM, Pollak M, Seidman CE, Seidman JG, Chou YH, Riccardi D, Hebert SC. Calcium-ion-sensing cell-surface receptors. N Engl J Med 1995; 333:234-40.
20. Manning AT, O'Brien N, Kerin MJ. Roles for the calcium sensing receptor in primary and metastatic cancer. Eur J Surg Oncol 2006; 32:693-7.
21. Liao J, Schneider A, Datta NS, McCauley LK. Extracellular calcium as a candidate mediator of prostate cancer skeletal metastasis. Cancer Res 2006; 66:9065-73.
22. Quinn SJ, Ye CP, Diaz R, Kifor O, Bai M, Vassilev P, Brown E. The Ca2+-sensing receptor: a target for polyamines. Am J Physiol 1997; 273:1315-23.
23. Peters U, Chatterjee N, Yeager M, Chanock SJ, Schoen RE, McGlynn KA, et al. Association of genetic variants in the calcium-sensing receptor with risk of colorectal adenoma. Cancer Epidemiol Biomarkers Prev 2004; 13:2181-6.
24. Wacholder J, Rothman N, Caporaso N. Population stratification in epidemiologic studies of common genetic variants and cancer: Quantification of bias. J Natl Cancer Inst 2000; 19:1151-8.
25. Cole DE, Vieth R, Trang HM, Wong BY, Hendy GN, Rubin LA. Association between total serum calcium and the A986S polymorphism of the calcium-sensing receptor gene. Mol Genet Metab 2001; 72:168-74.
26. Harding B, Curley AJ, Hannan FM, Christie PT, Bowl MR, Turner JJ, et al. Functional characterization of calcium sensing receptor polymorphisms and absence of association with indices of calcium homeostasis and bone mineral density. Clin Endocrinol (Oxf) 2006; 65:598-605.
27. Kung AW. Genotype and phenotype correlation of calcium-sensing receptor variants. Kidney Int 2007; 71:1085-6.
28. Scillitani A, Guarnieri V, De Geronimo S, Muscarella LA, Battista C, D'Agruma L, et al. Blood ionized calcium is associated with clustered polymorphisms in the carboxyl-terminal tail of the calcium-sensing receptor. J Clin Endocrinol Metab 2004; 89:5634-8.
29. Yano S, Sugimoto T, Kanzawa M, Tsukamoto T, Hattori T, Hattori S, et al. Association of polymorphic alleles of the calcium-sensing receptor gene with parathyroid hormone secretion in hemodialysis patients. Nephron 2000; 85:317-23. (Pubitemid 30665859)
30. Eren PA, Turan K, Berber I, Canbakan M, Kara M, Tellioglu G, et al. The clinical significance of parathyroid tissue calcium sensing receptor gene polymorphisms and expression levels in end-stage renal disease patients. Clin Nephrol 2009; 72:114-21.
31. Skinner HG, Schwartz GG. The relation of serum Parathyroid Hormone and serum calcium to serum levels of Prostate-Specific Antigen: A population-based study. Cancer Epidemiol Biomark 2009; 11:2869-73.